Isofol Medical AB Strategic Asset Allocation Index
Isofol Medical AB strategic asset allocation index. Isofol Medical AB (ISOFOL) has a Strategic Asset Allocation Index of 0.0% as of September 2025. Strategic assets (PP&E of Skr0.00 plus long-term investments of Skr-) total Skr0.00, measured against net assets of Skr120.62 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Isofol Medical AB to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Isofol Medical AB (2016–2024)
Strategic asset allocation index of Isofol Medical AB from 2016 to 2024. This chart shows how Isofol Medical AB's Strategic Asset Allocation Index has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the index stands at 0.0%, representing strategic assets of Skr0.00 against net assets of Skr120.62 Million SEK. Check ISOFOL tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Isofol Medical AB Strategic Asset Allocation Index by Year (2016–2024)
Isofol Medical AB strategic asset allocation index by year from 2016 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Isofol Medical AB from 2016 to 2024, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ISOFOL market cap overview.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | Skr0.00 | Skr0.00 | Skr- | Skr77.94 Million | ▼ 0.0 pp |
| 2023 | 0.0% | Skr3.00K | Skr3.00K | Skr- | Skr121.43 Million | ▼ -2.5 pp |
| 2022 | 2.5% | Skr4.01 Million | Skr4.01 Million | Skr- | Skr158.48 Million | ▲ +2.0 pp |
| 2021 | 0.5% | Skr1.75 Million | Skr1.75 Million | Skr- | Skr318.23 Million | ▼ -4.3 pp |
| 2020 | 4.9% | Skr3.26 Million | Skr3.26 Million | Skr- | Skr66.57 Million | ▲ +0.7 pp |
| 2019 | 4.2% | Skr4.43 Million | Skr4.43 Million | Skr- | Skr104.91 Million | ▲ +4.2 pp |
| 2018 | 0.0% | Skr132.00K | Skr132.00K | Skr- | Skr265.01 Million | ▼ 0.0 pp |
| 2017 | 0.1% | Skr189.00K | Skr189.00K | Skr- | Skr343.03 Million | ▼ -2.7 pp |
| 2016 | 2.8% | Skr171.00K | Skr171.00K | Skr- | Skr6.10 Million | — |